Wound healing activity of neferine in experimental diabetic rats through the inhibition of inflammatory cytokines and nrf-2 pathway
Source abstract
Abstract
The diabetic foot ulcer (DFU) may be associated with late healing and septic manifestation, subsequently lead to amputation which is an overpriced incident. Neferine is an alkaloid found lotus. Neferine possesses many physiological functions such as anti-inflammatory, antioxidant, antimicrobial activity and anticancer effect. The aim of the present study was to evaluate the effect of topical application based on neferine, in streptozotocin-induced diabetic incision wound models rats. The data demonstrated wound healing activities via macroscopic, biochemical, histological, immuno-histochemical, immunofluorescent and molecular methods. There was significant acceleration in wound closure rate, decrease in the period of re-epitalization, higher amount of collagen and protein content in neferine treated group when compared with diabetic wound control. Histological data evidence collagen formation in skin and marked granulation with more connective tissue markers. The augmentation of serum insulin and HDL was dissimilar with blood glucose reduction and decreased lipid level (TC, TG and LDL). The healing effect was additionally validated by decreased lipid peroxidation and enhanced antioxidants. Concurrently, the mRNA level of Nrf-2, collagen-1, TGF-β and α-SMA were decreased with Kaep-1 increased significantly. This enhancement was achieved through downregulation of inflammatory mediators such as nuclear factor kappa-light-chain-enhancer of activated B cells, tumour necrosis factor-α, interleukin-1β, interleukin-8, inducible nitric oxide synthase, and cyclooxygenase-2, and upregulation of growth factor such as in groups treated with neferine. The western blot results reveal the macrophage (CD 68 and CD 163) involved in wound healing markedly elevated. Hence, the results indicate that neferine significantly promotes a fast and efficient wound healing in diabetic rats.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bioactive natural compounds · Biological and pharmacological studies of plants · Phytochemistry and biological activity of medicinal plants
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Plastic surgery, the First Affiliated Hospital of Zhengzhou University
Department of Plastic surgery, Henan Provincial People's Hospital
Department of Burn surgery, the First Affiliated Hospital of Zhengzhou University
Funding
National Natural Science Foundation of China – Henan Joint Fund
References (35)
Show source-provided references
1. 10.1007/s13300-012-0004-910.1007/s13300-012-0004-9 ↗
2. 10.5312/wjo.v6.i1.6210.5312/wjo.v6.i1.62 ↗
3. 10.3390/ijms1807141910.3390/ijms18071419 ↗
4. 10.1089/wound.2011.030810.1089/wound.2011.0308 ↗
5. Wan Mohd Azizi WS, Sunzida NK, Azad AK. The screening of local herbs in treating non healing wounds and diabetic foot ulcers complications using nih 3T3 mouse fibroblast and RAW 264.7 mouse macrophage cells. Pharmacol Online. 2016;14:139–145.
6. 10.3389/fphar.2017.0023810.3389/fphar.2017.00238 ↗
7. Tang XQ, Co JG. Review on the pharmacological research of neferine. Chinese Pharmacol Bull. 2004;20(1):8–10.
8. 10.1016/j.lfs.2010.08.00510.1016/j.lfs.2010.08.005 ↗
9. 10.1186/s12906-018-2427-y10.1186/s12906-018-2427-y ↗
10. 10.13005/bpj/167910.13005/bpj/1679 ↗
11. 10.1016/S0021-9258(19)52451-610.1016/S0021-9258(19)52451-6 ↗
12. 10.1016/j.jep.2017.02.01710.1016/j.jep.2017.02.017 ↗
13. 10.1016/j.ijbiomac.2017.03.01410.1016/j.ijbiomac.2017.03.014 ↗
14. 10.1002/ptr.578610.1002/ptr.5786 ↗
15. 10.1016/j.burns.2016.10.01010.1016/j.burns.2016.10.010 ↗
16. 10.7717/peerj.360810.7717/peerj.3608 ↗
17. 10.2147/DDDT.S9696810.2147/DDDT.S96968 ↗
18. Anurag S, Pramod KS, Rakesh KS. Antidiabetic and wound healing activity of Catharanthus roseus L. in streptozotocin induced diabetic mice. Am J Phytomed Clin Ther. 2014;2(6):686–692.
19. 10.3923/rjmp.2011.392.40510.3923/rjmp.2011.392.405 ↗
20. 10.1016/j.jep.2017.08.00810.1016/j.jep.2017.08.008 ↗
21. 10.4103/0975-7406.13524810.4103/0975-7406.135248 ↗
22. Santosh RK, Rajkiran K, Sunil KP. Evaluation of incisional diabetic wound healing activity of ethanolic leave extract of Mimosa pudica L. in rats. Phyto. 2017;9(8):1143–1147.
23. 10.3390/medicines404007310.3390/medicines4040073 ↗
24. 10.3389/fendo.2018.0058610.3389/fendo.2018.00586 ↗
25. 10.21037/atm.2017.09.0310.21037/atm.2017.09.03 ↗
26. 10.1152/ajprenal.00502.201510.1152/ajprenal.00502.2015 ↗
27. 10.1152/ajpendo.00311.201710.1152/ajpendo.00311.2017 ↗
28. 10.4103/pm.pm_108_1710.4103/pm.pm_108_17 ↗
29. 10.1086/64473210.1086/644732 ↗
30. 10.1089/jmf.2016.379210.1089/jmf.2016.3792 ↗
31. 10.4103/0973-1296.17296110.4103/0973-1296.172961 ↗
32. 10.1111/j.1742-481X.2011.00924.x10.1111/j.1742-481X.2011.00924.x ↗
33. Abubakar AM, Arulselvan P, Cheah PS, Abas F, et al. Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model. Drug Des Devel Ther. 2015;10:1715–1730.
34. 10.1007/s10856-016-5821-310.1007/s10856-016-5821-3 ↗
35. 10.1016/j.cjtee.2017.12.00110.1016/j.cjtee.2017.12.001 ↗